PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11578111-0	2001	Inhibition of serum angiotensin-converting enzyme in rabbits after intravenous administration of enalaprilat-loaded intact erythrocytes.	Enalaprilat	97-108	angiotensin-converting enzyme	Oryctolagus cuniculus	20-49	
12651915-4	2003	Similar effects were obtained using CV-11974 (another AT1R blocker) and enalaprilat (another ACE inhibitor).	Enalaprilat	72-83	angiotensin-converting enzyme	Oryctolagus cuniculus	93-96	
11578111-2	2001	In this study, the inhibition time courses of serum angiotensin-converting enzyme (ACE) activity after intravenous administration of enalaprilat encapsulated in intact erythrocytes was evaluated and compared with free drug, in a rabbit model.	Enalaprilat	133-144	angiotensin-converting enzyme	Oryctolagus cuniculus	52-81	
11578111-2	2001	In this study, the inhibition time courses of serum angiotensin-converting enzyme (ACE) activity after intravenous administration of enalaprilat encapsulated in intact erythrocytes was evaluated and compared with free drug, in a rabbit model.	Enalaprilat	133-144	angiotensin-converting enzyme	Oryctolagus cuniculus	83-86	
10942157-14	2000	Our data suggest that ACE inhibitors enalaprilat, ramiprilat, and fosinopril produce a significant ocular hypotensive effect in acute and chronic models of ocular hypertension in rabbits.	Enalaprilat	37-48	angiotensin-converting enzyme	Oryctolagus cuniculus	22-25	
3503919-7	1987	Other ACE inhibitors such as captopril (0.1%) and enalaprilic acid (0.01%) also reduced IOP by 4.0 +/- 0.4 and 4.7 +/- 0.4 mmHg, respectively.	Enalaprilat	50-66	angiotensin-converting enzyme	Oryctolagus cuniculus	6-9	
10588480-3	1999	Aortic segments were cultured in medium containing a broad concentration range of the ACE inhibitor enalaprilat (0-100 microM).	Enalaprilat	100-111	angiotensin-converting enzyme	Oryctolagus cuniculus	86-89	
9869501-6	1998	Angiotensin-converting enzyme (ACE) inhibition with enalaprilat revealed a larger, more rapid decrease in MAP in response to omega-CTX (-19 +/- 4 mm Hg from 65 +/- 1 mm Hg after 18 +/- 2 min; n = 6) compared with the control group.	Enalaprilat	52-63	angiotensin-converting enzyme	Oryctolagus cuniculus	0-29	
9869501-6	1998	Angiotensin-converting enzyme (ACE) inhibition with enalaprilat revealed a larger, more rapid decrease in MAP in response to omega-CTX (-19 +/- 4 mm Hg from 65 +/- 1 mm Hg after 18 +/- 2 min; n = 6) compared with the control group.	Enalaprilat	52-63	angiotensin-converting enzyme	Oryctolagus cuniculus	31-34	
10350000-5	1999	With respect to structure-function, ACE inhibitor affinity was strongly correlated with drug lipophilicity (r = 0.944, p < 0.001 for all ACE inhibitors; r = 0.983, p < 0.001 without enalaprilat, quinaprilat and quinapril).	Enalaprilat	188-199	angiotensin-converting enzyme	Oryctolagus cuniculus	36-39	
7714339-8	1995	The conversion of BK into des-Arg9-BK was generally efficient, and the persistence and concentration of both peptides were increased in the presence of enalaprilat an inhibitor of the angiotensin converting enzyme (ACEI).	Enalaprilat	152-163	angiotensin-converting enzyme	Oryctolagus cuniculus	184-213	
7714339-8	1995	The conversion of BK into des-Arg9-BK was generally efficient, and the persistence and concentration of both peptides were increased in the presence of enalaprilat an inhibitor of the angiotensin converting enzyme (ACEI).	Enalaprilat	152-163	angiotensin-converting enzyme	Oryctolagus cuniculus	215-219	
34775060-1	2022	Formulations on the base of an inhibitor of angiotensin-converting enzyme, enalaprilat, were prepared by the inclusion of the drug into calcium phosphate (CaP)-particles in situ, followed by the covering of the particles with 5 kDa chitosan or 72 kDa glycol chitosan and cross-linking with sodium tripolyphosphate.	Enalaprilat	75-86	angiotensin-converting enzyme	Oryctolagus cuniculus	44-73	
6199659-4	1984	This hydrolysis is inhibited by the angiotensin-converting enzyme inhibitors captopril, MK-422, and EDTA, and is dependent on the concentration of chloride ion.	Enalaprilat	88-94	angiotensin-converting enzyme	Oryctolagus cuniculus	36-65	
2983065-3	1985	Hydrolysis of BPAP (4.2 microM) was 64.1 +/- 3.3% at 37 degrees C and was significantly decreased (P less than .01) to 10.1 +/- 8.7% by the addition of the ACE inhibitor, MK422 (10(-6) M).	Enalaprilat	171-176	angiotensin-converting enzyme	Oryctolagus cuniculus	156-159